AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Bispectral Index and First-Pass Intubation

Recruitingn/aAges 18 Years - anyAllAkdeniz University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This prospective observational study aims to evaluate the association between anesthetic depth, measured by the Bispectral Index (BIS), and first-pass endotracheal intubation success in adult patients undergoing rapid sequence intubation (RSI) in the emergency department. Endotracheal intubation is one of the most critical procedures performed in emergency medicine. Multiple intubation attempts are associated with an increased risk of adverse events, including hypoxemia, aspiration, cardiovascular complications, and death. Although several factors influence first-pass intubation success, the contribution of anesthetic depth at the time of intubation has not been adequately investigated in the emergency department. Patients for whom the treating emergency physician decides to perform RSI will undergo noninvasive BIS monitoring using a disposable forehead sensor. The physician performing

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older * Patients undergoing rapid sequence intubation (RSI) in the emergency department * No traumatic injury to the frontal region that would interfere with placement of the Bispectral Index (BIS) sensor Exclusion Criteria: * Age younger than 18 years * Pregnant patients * Patients with cardiac arrest or hemodynamic instability at the time of enrollment * Patients intubated without the rapid sequence intubation (RSI) protocol * Refusal to participate in the study (by the patient or, where applicable, a legally authorized representative)
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Akdeniz University Hospital
Antalya, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy